Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study.

Front Oncol · 2020 · PMC7591744 · PMID 33154952

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

After treatment discontinuation a significant trend toward reversibility was also documented, with a progressive corneal epithelium and sub-basal nerve plexus regeneration.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.